Intelligent Bio Solutions shares jumped pre-market after announcing the first shipment of its Intelligent Fingerprinting Drug Screening Readers. Produced with partner Syrma Johari MedTech, the deal quadruples manufacturing capacity and cuts costs by 40%. This should boost gross margins by 20 percentage points as the company prepares for US market entry.